In the BioHarmony Drug Report Database

"Preview" Icon

Rivastigmine

Exelon, Prometax, Rivastigmine 1 A Pharma, Rivastigmine Hexal, Rivastigmine Sandoz (rivastigmine) is a small molecule pharmaceutical. Rivastigmine was first approved as Exelon on 1998-05-11. It is used to treat alzheimer disease in the USA. It has been approved in Europe to treat alzheimer disease, dementia, and parkinson disease. The pharmaceutical is active against acetylcholinesterase and cholinesterase.

 

Trade Name

 

Exelon, Prometax, Rivastigmine 1 A Pharma, Rivastigmine Hexal, Rivastigmine Sandoz
 

Common Name

 

rivastigmine
 

ChEMBL ID

 

CHEMBL636
 

Indication

 

alzheimer disease, dementia, parkinson disease
 

Drug Class

 

Cholinesterase inhibitors (physostigmine type)

Image (chem structure or protein)

Rivastigmine structure rendering